Modular therapy approach in metastatic castration-refractory prostate cancer

被引：0
|
作者：
B. Walter
S. Rogenhofer
M. Vogelhuber
A. Berand
W. F. Wieland
R. Andreesen
A. Reichle
机构：
[1] University Hospital Erlangen,Department of Urology
[2] University Hospital Bonn,Department of Urology
[3] University Hospital Regensburg,Department of Hematology and Oncology
[4] University Hospital Regensburg,Department of Urology
来源：
World Journal of Urology | 2010年 / 28卷
关键词：
Castrate-resistant prostate cancer; Modular therapy; Anti-inflammatoric agents;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：745 / 750
页数：5
相关论文
共 50 条
  • [1] Modular therapy approach in metastatic castration-refractory prostate cancer
    Walter, B.
    Rogenhofer, S.
    Vogelhuber, M.
    Berand, A.
    Wieland, W. F.
    Andreesen, R.
    Reichle, A.
    WORLD JOURNAL OF UROLOGY, 2010, 28 (06) : 745 - 750
  • [2] Recent Advances in the Treatment for Metastatic Castration-Refractory Prostate Cancer
    Kwong, P. W. K.
    HONG KONG JOURNAL OF RADIOLOGY, 2013, 16 (04): : S44 - S49
  • [3] Third-line Therapy for Patients with metastatic castration-refractory Prostate Cancer (mCRPC)
    Rexer, H.
    Hammerer, P.
    Merseburger, A.
    AKTUELLE UROLOGIE, 2019, 50 (02) : 144 - 145
  • [4] Pain predicts overall survival in men with metastatic castration-refractory prostate cancer
    Halabi, Susan
    Vogelzang, Nicholas J.
    Kornblith, Alice B.
    Ou, San-San
    Kantoff, Philip W.
    Dawson, Nancy A.
    Small, Eric J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) : 2544 - 2549
  • [5] Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate Cancer
    Berghen, Charlien
    Joniau, Steven
    Ost, Piet
    Poels, Kenneth
    Everaerts, Wouter
    Decaestecker, Karel
    Haustermans, Karin
    Devos, Gaetan
    De Meerleer, Gert
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (02): : 305 - 309
  • [6] Castration-refractory prostate cancer: New drugs in the pipeline
    Dirk Schrijvers
    Peter Van Erps
    Jim Cortvriend
    Advances in Therapy, 2010, 27 : 285 - 296
  • [7] Perspectives on mTOR Inhibitors for Castration-Refractory Prostate Cancer
    Burgio, Salvatore L.
    Fabbri, Francesco
    Seymour, Ian J.
    Zoli, Wainer
    Amadori, Dino
    De Giorgi, Ugo
    CURRENT CANCER DRUG TARGETS, 2012, 12 (08) : 940 - 949
  • [8] New Therapeutic Agents for Castration-Refractory Prostate Cancer
    Patten, David Y.
    Sartor, Oliver
    CLINICAL GENITOURINARY CANCER, 2009, 7 (02) : E4 - E6
  • [9] Current possibilities of treatment for visceral metastases in patients with metastatic castration-refractory prostate cancer
    Govorov, A. V.
    Moiseenko, T. N.
    ONKOUROLOGIYA, 2013, 9 (02): : 53 - 56
  • [10] Castration-Refractory Prostate Cancer: New Drugs in the Pipeline
    Schrijvers, Dirk
    Van Erps, Peter
    Cortvriend, Jim
    ADVANCES IN THERAPY, 2010, 27 (05) : 285 - 296
12345